Takeda Pharmaceutical has formed a five-year collaboration with Maverick Therapeutics, a Brisbane, California-based private start-up biotechnology company, to develop Maverick’s T-cell engagement platform in a $125-million deal. The $125 million…
Amgen has entered into a new six-year sourcing and supply agreement with DaVita, a kidney-care company based in Denver, Colorado for Amgen’s anemia drugs, Epogen (epoetin alfa) and Aransep (darbepoetin…
Eli Lilly and Company has expanded an existing immuno-oncology collaboration with Merck & Co., through a subsidiary, to add a new study of Lilly’s anti-cancer drug, Lartruvo (olaratumab), in combination…
Merck KGaA has entered into a licensing agreement with Vertex Pharmaceuticals, a Boston-based biotechnology company, for the worldwide development and commercialization of four research and development programs for cancer treatments.…
A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring news from Merck & Co and Mylan. Editor’s Note: This article…
Perrigo has changed its reporting segments to better align with the company’s organizational structure. Beginning with the fourth quarter of calendar year 2016, the Perrigo’s new reporting segments are: Consumer…
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Gilead. Editor’s Note: This article is updated on a continuous basis for news announced from Wednesday…
Court Upholds Patent for Lilly’s Blockbuster Vitamin Regimen
Eli Lilly and Company has received a favorable ruling from the US Court of Appeals for the Federal Circuit, which upheld a federal district court’s decision regarding validity and infringement…
Merck KGaA has partnered with Palantir Technologies, a developer of data integration and analysis software headquartered in Palo Alto, California, to use Palantir’s data analytics capabilities to help Merck develop…
AbbVie has formed a collaboration with Zebra Biologics, an emerging preclinical-stage biotechnology company headquartered in Concord, Massachusetts, to discover agonist antibody therapeutics for inflammatory diseases. Under the agreement, Zebra will…